Research ExplorerScientific StaffWalter Fiedler Publications

Prof.Dr. ID: 50717

Walter Fiedler

graph of relations
Affiliations
1 - 50 out of 195Page size: 50

Publications

  1. 2024

  2. Molecular subgroups of T-cell acute lymphoblastic leukemia in adults treated according to pediatric-based GMALL protocols

    Neumann, M., Beder, T., Bastian, L., Hänzelmann, S., Bultmann, M., Wolgast, N., Hartmann, A., Trautmann, H., Ortiz-Tanchez, J., Schlee, C., Schroeder, M., Fransecky, L., Vosberg, S., Fiedler, W., Alakel, N., Heberling, L., Kondakci, M., Starck, M., Schwartz, S., Raffel, S., Müller-Tidow, C., Schneller, F., Reichle, A., Burmeister, T., Greif, P. A., Brüggemann, M., Gökbuget, N. & Baldus, C. D., 06.2024, In: LEUKEMIA. 38, 6, p. 1213-1222 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. Developmental trajectories and cooperating genomic events define molecular subtypes of BCR::ABL1-positive ALL

    Bastian, L., Beder, T., Barz, M. J., Bendig, S., Bartsch, L., Walter, W., Wolgast, N., Brändl, B., Rohrandt, C., Hansen, B-T., Hartmann, A. M., Iben, K., Das Gupta, D., Denker, M., Zimmermann, J., Wittig, M., Chitadze, G., Neumann, M., Schneller, F., Fiedler, W., Steffen, B., Stelljes, M., Faul, C., Schwartz, S., Müller, F-J., Cario, G., Harder, L., Haferlach, C., Pfeifer, H., Gökbuget, N., Brüggemann, M. & Baldus, C. D., 04.04.2024, In: BLOOD. 143, 14, p. 1391-1398 8 p.

    Research output: SCORING: Contribution to journal › Short publication › Research › peer-review

  4. Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia

    Pratz, K. W., Jonas, B. A., Pullarkat, V., Thirman, M. J., Garcia, J. S., Döhner, H., Récher, C., Fiedler, W., Yamamoto, K., Wang, J., Yoon, S-S., Wolach, O., Yeh, S-P., Leber, B., Esteve, J., Mayer, J., Porkka, K., Illés, Á., Lemoli, R. M., Turgut, M., Ku, G., Miller, C., Zhou, Y., Zhang, M., Chyla, B., Potluri, J. & DiNardo, C. D., 04.2024, In: AM J HEMATOL. 99, 4, p. 615-624 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. Therapy with hypomethlyating agents/venetoclax in patients with newly diagnosed acute myeloid leukaemia requiring admission to the intensive care unit: Possible reduction in side effects with preserved efficacy

    Fiedler, W., 04.2024, In: BRIT J HAEMATOL. 204, 4, p. 1135-1136 2 p.

    Research output: SCORING: Contribution to journal › Comment/debate › Research

  6. Expression of CD39 is associated with T cell exhaustion in ovarian cancer and its blockade reverts T cell dysfunction

    Marius, W., Leticia, O-F., Friedrich, K-N., Stephan, M., Louisa, H., Tabea, S., Elisa, S., Pauline, W., Yi, D., Qi, M., Barbara, S., Carsten, B., Walter, F., Jasmin, W. & Franziska, B., 2024, In: ONCOIMMUNOLOGY. 13, 1, p. 2346359

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. 2023

  8. Case Report of a DDX41 Germline Mutation in a Family with Multiple Relatives Suffering from Leukemia

    Wagner, J. N., Al-Bazaz, M., Forstreuter, A., Hammada, M. I., Hille, J., Papingi, D., Bokemeyer, C. & Fiedler, W., 27.12.2023, In: BIOMEDICINES. 12, 1, 64.

    Research output: SCORING: Contribution to journal › Case report › Research › peer-review

  9. Rezidivierte/refraktäre AML – Herausforderungen in Diagnostik und Therapie

    Modemann, F., Ghandili, S., Bokemeyer, C. & Fiedler, W., 01.11.2023, In: Kompendium ... Hämatologie/Onkologie. 2023, 21-27, p. 21-27

    Research output: SCORING: Contribution to journal › Training articles › Transfer › peer-review

  10. Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemia

    Gottschlich, A., Thomas, M., Grünmeier, R., Lesch, S., Rohrbacher, L., Igl, V., Briukhovetska, D., Benmebarek, M-R., Vick, B., Dede, S., Müller, K., Xu, T., Dhoqina, D., Märkl, F., Robinson, S., Sendelhofert, A., Schulz, H., Umut, Ö., Kavaka, V., Tsiverioti, C. A., Carlini, E., Nandi, S., Strzalkowski, T., Lorenzini, T., Stock, S., Müller, P. J., Dörr, J., Seifert, M., Cadilha, B. L., Brabenec, R., Röder, N., Rataj, F., Nüesch, M., Modemann, F., Wellbrock, J., Fiedler, W., Kellner, C., Beltrán, E., Herold, T., Paquet, D., Jeremias, I., von Baumgarten, L., Endres, S., Subklewe, M., Marr, C. & Kobold, S., 11.2023, In: NAT BIOTECHNOL. 41, 11, p. 1618-1632 15 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. A phase 1b study of venetoclax and alvocidib in patients with relapsed/refractory acute myeloid leukemia

    Jonas, B. A., Hou, J-Z., Roboz, G. J., Alvares, C. L., Jeyakumar, D., Edwards, J. R., Erba, H. P., Kelly, R. J., Röllig, C., Fiedler, W., Brackman, D., Siddani, S. R., Chyla, B., Hilger-Rolfe, J. & Watts, J. M., 10.2023, In: HEMATOL ONCOL. 41, 4, p. 743-752 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Regulation of coagulation activation in newly diagnosed AML by the heme enzyme myeloperoxidase

    Langer, F., Quick, H., Beitzen-Heineke, A., Janjetovic, S., Mäder, J., Lehr, C., Bokemeyer, C., Kuta, P., Renné, T., Fiedler, W., Beckmann, L., Klingler, F. & Rolling, C. C., 09.2023, In: THROMB RES. 229, p. 155-163 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. The prognostic impact of lymphoma perforation in patients with primary gastrointestinal lymphoma - a single-center analysis

    Modemann, F., Ahmadi, P., von Kroge, P. H., Weidemann, S., Bokemeyer, C., Dierlamm, J., Fiedler, W. & Ghandili, S., 08.08.2023, In: LEUKEMIA LYMPHOMA. 64, 11, p. 1801-1810 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. The Clinical Significance of CD73 in Cancer

    Bach, N., Winzer, R., Tolosa, E., Fiedler, W. & Brauneck, F., 21.07.2023, In: INT J MOL SCI. 24, 14, 11759.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  15. Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09-09): a randomised, open-label, multicentre, phase 3 trial

    Döhner, H., Weber, D., Krzykalla, J., Fiedler, W., Kühn, M. W. M., Schroeder, T., Mayer, K., Lübbert, M., Wattad, M., Götze, K., Fransecky, L., Koller, E., Wulf, G., Schleicher, J., Ringhoffer, M., Greil, R., Hertenstein, B., Krauter, J., Martens, U. M., Nachbaur, D., Samra, M. A., Machherndl-Spandl, S., Basara, N., Leis, C., Schrade, A., Kapp-Schwoerer, S., Cocciardi, S., Bullinger, L., Thol, F., Heuser, M., Paschka, P., Gaidzik, V. I., Saadati, M., Benner, A., Schlenk, R. F., Döhner, K., Ganser, A. & German–Austrian AML Study Group, 07.2023, In: LANCET HAEMATOL. 10, 7, p. e495-e509

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. Palbociclib in Acute Leukemias With KMT2A-rearrangement: Results of AMLSG 23-14 Trial

    Gaidzik, V. I., Paschka, P., Schlenk, R. F., Weber, D., Fröhling, S., Krämer, A., Wäsch, R., Westermann, J., Mayer, K., de Wit, M., Fiedler, W., Benner, A., Heuser, M., Thol, F., Döhner, K., Ganser, A. & Döhner, H., 05.2023, In: HEMASPHERE. 7, 5, p. e877

    Research output: SCORING: Contribution to journal › Letter › Research › peer-review

  17. Therapie der rezidivierten/refraktären akuten myeloischen Leukämie: Aktuelle Behandlungsoptionen bei einem Rezidiv

    Modemann, F., Ghandili, S., Bokemeyer, C. & Fiedler, W., 05.04.2023, In: Im Fokus Onkologie. 26, 2, p. 18-23

    Research output: SCORING: Contribution to journal › Training articles › Transfer › peer-review

  18. Abdominal emergency surgery in patients with hematological malignancies: a retrospective single-center analysis

    von Kroge, P. H., Duprée, A., Mann, O., Izbicki, J. R., Wagner, J., Ahmadi, P., Weidemann, S., Adjallé, R., Kröger, N., Bokemeyer, C., Fiedler, W., Modemann, F. & Ghandili, S., 06.02.2023, In: WORLD J EMERG SURG. 18, 1, p. 12

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapy

    Klement, P., Fiedler, W., Gabdoulline, R., Dallmann, L-K., Wienecke, C. P., Schiller, J., Kandziora, C., Teich, K., Heida, B., Büttner, K., Brandes, M., Funke, C., Wichmann, M., Othman, B., Chromik, J., Amberg, S., Kebenko, M., Schlipfenbacher, V., Wilke, A. C., Modemann, F., Janning, M., Serve, H., Bokemeyer, C., Theile, S., Deppermann, U., Kranich, A. L., Ganser, A., Thol, F. & Heuser, M., 02.2023, In: ANN HEMATOL. 102, 2, p. 323-328 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. Broadening the horizon: potential applications of CAR-T cells beyond current indications

    Karsten, H., Matrisch, L., Cichutek, S., Fiedler, W., Alsdorf, W. & Block, A., 2023, In: FRONT IMMUNOL. 14, p. 1285406

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  21. Immunosuppressive M2 TAMs represent a promising target population to enhance phagocytosis of ovarian cancer cells in vitro

    Brauneck, F., Schmalfeldt, B., Muschhammer, J., Sturmheit, T., Ackermann, C., Haag, F., Schulze Zur Wiesch, J., Ding, Y., Qi, M., Hell, L., Schmalfeldt, B., Bokemeyer, C., Fiedler, W. & Wellbrock, J., 2023, In: FRONT IMMUNOL. 14, p. 1250258

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. 2022

  23. Long-term follow-up of VIALE-C in patients with untreated AML ineligible for intensive chemotherapy

    Wei, A. H., Panayiotidis, P., Montesinos, P., Laribi, K., Ivanov, V., Kim, I., Novak, J., Champion, R., Fiedler, W., Pagoni, M., Bergeron, J., Ting, S., Hou, J., Anagnostopoulos, A., McDonald, A., Murthy, V., Yamauchi, T., Wang, J., Jiang, Q., Sun, Y., Chyla, B., Mendes, W. L. & DiNardo, C. D., 22.12.2022, In: BLOOD. 140, 25, p. 2754-2756 3 p., blood.2022016963.

    Research output: SCORING: Contribution to journal › Letter › Research

  24. Die akute Promyelozytenleukämie - ein hämatologischer Notfall

    Modemann, F., Ghandili, S., Zhurba, I., Langer, F., Bokemeyer, C. & Fiedler, W., 12.12.2022, In: InFo Hämatologie + Onkologie. 25, 12, p. 10–15 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. Therapie der akuten Promyelozytenleukämie

    Modemann, F., Ghandili, S., Bokemeyer, C. & Fiedler, W., 12.12.2022, In: InFo Hämatologie + Onkologie. 25, 12, p. 16–21 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. An open-label, phase I/II trial to determine the maximum tolerated dose and investigate safety, pharmacokinetics and efficacy of BI 836858, an unconjugated anti-CD33 monoclonal antibody, in combination with decitabine in patients with acute myeloid leukemia

    Fiedler, W., Montesinos, P., Schliemann, C., Middeke, J., Vasu, S., Scholz, C. W., Esteve, J., Mondal, S., Rüter, B., Burkard, U., Osswald, A. & Blum, W., 01.12.2022, In: HAEMATOLOGICA. 107, 12, p. 2977-2982 6 p.

    Research output: SCORING: Contribution to journal › Letter › Research › peer-review

  27. Clinical features of hepatitis E infections in patients with hematologic disorders

    Ghandili, S., Lindhauer, C., Pischke, S., Zur Wiesch, J. S., Von Kroge, P. H., Polywka, S., Bokemeyer, C., Fiedler, W., Kröger, N., Ayuk, F., Adjallé, R. & Modemann, F., 01.12.2022, In: HAEMATOLOGICA. 107, 12, p. 2870-2883 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. TIGIT blockade repolarizes AML-associated TIGIT+ M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosis

    Brauneck, F., Fischer, B., Witt, M., Muschhammer, J., Oelrich, J., da Costa Avelar, P. H., Tsoka, S., Bullinger, L., Seubert, E., Smit, D. J., Bokemeyer, C., Ackermann, C., Wellbrock, J., Haag, F. & Fiedler, W., 12.2022, In: J IMMUNOTHER CANCER. 10, 12, e004794.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. Retrospective analysis of three induction chemotherapy regimens in acute myeloid leukemia including CPX-351, cytarabine/daunorubicin with and without the addition of cladribine

    Klingler, F., Alsdorf, W. H., Ghandili, S., Wolschke, C., Brauneck, F., Bokemeyer, C., Fiedler, W., Modemann, F. & Karagiannis, P., 11.2022, In: LEUKEMIA LYMPHOMA. 63, 11, p. 2645-2651 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. Aktuelle Therapieoptionen bei rezidivierter/refraktärer AML

    Modemann, F., Ghandili, S., Oelrich, J., Bokemeyer, C. & Fiedler, W., 12.10.2022, In: InFo Hämatologie + Onkologie. 25, 10, p. 18-23 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Transfer › peer-review

  31. AML-440 Prognosis of Molecularly-Defined Secondary Acute Myeloid Leukemia Patients

    Mecklenbrauck, R., Borchert, N., Klement, P., Funke, C., Brandes, M., Dallmann, L-K., Fiedler, W., Krauter, J., Trummer, A., Hertenstein, B., Voβ, A., Lübbert, M., Gaidzik, V., Döhner, K., Döhner, H., Ganser, A., Thol, F. & Heuser, M., 01.10.2022, In: CL LYMPH MYELOM LEUK. 22, Suppl 2, p. S251-S252

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  32. Midostaurin plus intensive chemotherapy for younger and older Patients with AML and FLT3 internal tandem duplications

    Döhner, H., Weber, D., Krzykalla, J., Fiedler, W., Wulf, G. G., Salih, H. R., Lübbert, M., Kühn, M., Schroeder, T., Salwender, H., Götze, K. S., Westermann, J., Fransecky, L., Mayer, K., Hertenstein, B., Ringhoffer, M., Tischler, H-J., Machherndl-Spandl, S., Schrade, A., Paschka, P., Gaidzik, V. I., Theis, F., Thol, F. R., Heuser, M., Schlenk, R. F., Bullinger, L., Saadati, M., Benner, A., Larson, R. A., Stone, R. M., Döhner, K., Ganser, A. & German-Austrian AML Study Group (AMLSG), 27.09.2022, In: BLOOD ADV. 6, 18, p. 5345-5355 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. Überblick zur Diagnostik und Therapie neu diagnostizierter Patienten mit AML

    Modemann, F., Ghandili, S., Bokemeyer, C. & Fiedler, W., 01.09.2022, In: Onkologie heute. 2022, 09, p. 22-29

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. Mebendazole's Conformational Space and Its Predicted Binding to Human Heat-Shock Protein 90

    Fiedler, W., Freisleben, F., Wellbrock, J. & Kirschner, K. N., 08.08.2022, In: J CHEM INF MODEL. 62, 15, p. 3604-3617 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. Timing of response with venetoclax combination treatment in patients with newly diagnosed acute myeloid leukemia

    Jonas, B. A., Wei, A. H., Recher, C., DiNardo, C. D., Jang, J-H., Pratz, K., Panayiotidis, P., Montesinos, P., Yeh, S-P., Ivanov, V., Fiedler, W., Yamauchi, T., Duan, Y., Mendes, W., Potluri, J., Tews, B. & Ofran, Y., 08.2022, In: AM J HEMATOL. 97, 8, p. E299-E303

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  36. COVID-19 and Adult Acute Leukemia: Our Knowledge in Progress

    Modemann, F., Ghandili, S., Schmiedel, S., Weisel, K., Bokemeyer, C. & Fiedler, W., 29.07.2022, In: CANCERS. 14, 15, 3711.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  37. Aktueller diagnostischer Standard und Risikostratifizierung der AML

    Ghandili, S., Modemann, F., Oelrich, J., Bokemeyer, C. & Fiedler, W., 27.07.2022, In: InFo Hämatologie + Onkologie. 25, 7-8, p. 10–15

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  38. Erstlinientherapie intensiv-therapierbarer AML Patient*innen

    Modemann, F., Ghandili, S., Bokemeyer, C. & Fiedler, W., 27.07.2022, In: InFo Hämatologie + Onkologie. 25, 7-8, p. 16-21 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  39. Patientin mit therapieinduzierter sekundärer akuter myeloischer Leukämie (t-AML)

    Fiedler, W., 22.07.2022

    Research output: Non-textual form › Digital or Visual Products

  40. Impact of Venetoclax and Azacitidine in Treatment-Naïve Patients with Acute Myeloid Leukemia and IDH1/2 Mutations

    Pollyea, D. A., DiNardo, C. D., Arellano, M. L., Pigneux, A., Fiedler, W., Konopleva, M., Rizzieri, D. A., Smith, B. D., Shinagawa, A., Lemoli, R. M., Dail, M., Duan, Y., Chyla, B., Potluri, J., Miller, C. L. & Kantarjian, H. M., 01.07.2022, In: CLIN CANCER RES. 28, 13, p. 2753-2761 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. Donor-transmitted extramedullary acute myeloid leukaemia after living donor kidney transplantation

    Ghandili, S., Kluger, M. A., Leitner, T., Grahammer, F., Kirchner, L., Modemann, F., Achilles, E-G., Kreipe, H. H., Klein, J., Steinemann, D., Wolschke, C., Fischer, L., Bokemeyer, C., Fiedler, W., Huber, T. B., Alsdorf, W. H. & Mahmud, M., 07.2022, In: BRIT J HAEMATOL. 198, 1, p. 199-202 4 p.

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  42. Diagnostic Utility of Bronchoalveolar Lavage in Patients with Acute Leukemia under Broad-Spectrum Anti-Infective Treatment

    Ghandili, S., von Kroge, P. H., Simon, M., Henes, F. O., Rohde, H., Hoffmann, A., Lindeman, N. B., Bokemeyer, C., Fiedler, W. & Modemann, F., 02.06.2022, In: CANCERS. 14, 11, 2773.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia

    Pratz, K. W., Panayiotidis, P., Recher, C., Wei, X., Jonas, B. A., Montesinos, P., Ivanov, V., Schuh, A. C., DiNardo, C. D., Novak, J., Pejsa, V., Stevens, D., Yeh, S-P., Kim, I., Turgut, M., Fracchiolla, N., Yamamoto, K., Ofran, Y., Wei, A. H., Bui, C. N., Benjamin, K., Kamalakar, R., Potluri, J., Mendes, W., Devine, J. & Fiedler, W., 20.04.2022, In: BLOOD CANCER J. 12, 4, 71.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody gatipotuzumab with the anti-EGFR tomuzotuximab in patients with refractory solid tumors

    Ochsenreither, S., Fiedler, W. M., Conte, G. D., Macchini, M., Matos, I., Habel, B., Ahrens-Fath, I., Raspagliesi, F., Lorusso, D., Keilholz, U., Rolling, C., Kebenko, M., Klinghammer, K. F., Saavedra, O., Baumeister, H., Zurlo, A. & Garralda, E., 06.04.2022, In: ESMO OPEN. 7, 2, 100447.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. Tissue-Specific Expression of TIGIT, PD-1, TIM-3, and CD39 by γδ T Cells in Ovarian Cancer

    Weimer, P., Wellbrock, J., Sturmheit, T., Ferrer, L. O., Ding, Y., Menzel, S., Witt, M., Hell, L., Schmalfeldt, B., Bokemeyer, C., Fiedler, W. & Brauneck, F., 11.03.2022, In: CELLS-BASEL. 11, 6, 964.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. COVID-19 and seasonal influenza: a comparative analysis in patients with hematological malignancies

    Modemann, F., Niederwieser, C., Weisel, K., Bokemeyer, C., Fiedler, W. & Ghandili, S., 03.2022, In: LEUKEMIA LYMPHOMA. 63, 3, p. 664-671 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. Efficacy of Tigecycline as Salvage Therapy in Multidrug-Resistant Febrile Neutropenia in Patients with Acute Leukemia-A Single Center Analysis

    Modemann, F., Härterich, S., Schulze Zur Wiesch, J., Rohde, H., Lindeman, N. B., Bokemeyer, C., Fiedler, W. & Ghandili, S., 19.01.2022, In: ANTIBIOTICS-BASEL. 11, 2, 128.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. 2021

  49. The BET bromodomain inhibitor ZEN-3365 targets the Hedgehog signaling pathway in acute myeloid leukemia

    Wellbrock, J., Behrmann, L., Muschhammer, J., Modemann, F., Khoury, K., Brauneck, F., Bokemeyer, C., Campeau, E. & Fiedler, W., 12.2021, In: ANN HEMATOL. 100, 12, p. 2933-2941 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. Combined Blockade of TIGIT and CD39 or A2AR Enhances NK-92 Cell-Mediated Cytotoxicity in AML

    Brauneck, F., Seubert, E., Wellbrock, J., Schulze Zur Wiesch, J., Duan, Y., Magnus, T., Bokemeyer, C., Koch-Nolte, F., Menzel, S. & Fiedler, W., 29.11.2021, In: INT J MOL SCI. 22, 23, 12919.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  51. Long-term quality of life of patients with acute promyelocytic leukemia treated with arsenic trioxide vs chemotherapy

    Efficace, F., Platzbecker, U., Breccia, M., Cottone, F., Carluccio, P., Salutari, P., Di Bona, E., Borlenghi, E., Autore, F., Levato, L., Finizio, O., Mancini, V., D'Ardia, S., Schlenk, R. F., Melillo, L., Fumagalli, M., Fiedler, W., Beltrami, G., Fracchiolla, N. S., Bernardi, M., Fazi, P., Annibali, O., Mayer, K., Voso, M. T. & Vignetti, M., 09.11.2021, In: BLOOD ADV. 5, 21, p. 4370-4379 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  52. Bone Marrow-Resident Vδ1 T Cells Co-express TIGIT With PD-1, TIM-3 or CD39 in AML and Myeloma

    Brauneck, F., Weimer, P., Schulze zur Wiesch, J., Weisel, K. C., Leypoldt, L. B., Vohwinkel, G., Fritzsche, B., Bokemeyer, C., Wellbrock, J. & Fiedler, W., 08.11.2021, In: FRONT MED-LAUSANNE. 8, p. 763773 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  53. Cluster of differentiation 33 single nucleotide polymorphism rs12459419 is a predictive factor in patients with nucleophosmin1 mutated acute myeloid leukemia receiving gemtuzumab ozogamicin

    Teich, K., Krzykalla, J., Kapp-Schwoerer, S., Gaidzik, V. I., Schlenk, R. F., Paschka, P., Weber, D., Fiedler, W., Kühn, M. W. M., Schroeder, T., Mayer, K., Lübbert, M., Ramachandran, D., Benner, A., Ganser, A., Döhner, H., Heuser, M., Döhner, K. & Thol, F., 01.11.2021, In: HAEMATOLOGICA. 106, 11, p. 2986-2989 4 p.

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  54. Loss of CD22 expression and expansion of a CD22dim subpopulation in adults with relapsed/refractory B-lymphoblastic leukaemia after treatment with Inotuzumab-Ozogamicin

    Reinert, J., Beitzen-Heineke, A., Wethmar, K., Stelljes, M., Fiedler, W. & Schwartz, S., 11.2021, In: ANN HEMATOL. 100, 11, p. 2727-2732 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 3 4 Next